Author

Adnan M. Nagrial

The University of SydneyORCID 0000-0003-0275-2479Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Assay:proteomics· 1

Frequent Co-Authors

Anthony James GilliD· 2 shared Jaswinder Singh SamraiD· 2 shared Lisa Glen HorvathiD· 2 shared Adel T. ArefiD· 1 shared Adriana Aguilar‐MahechaiD· 1 shared Alexander SwarbrickiD· 1 shared Alexis Ang· 1 shared Alice M. H. Tran· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anthony James GillORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 23, 2026

Pulsed priming with the FAK inhibitor narmafotinib enhances both gemcitabine/Abraxane and FOLFIRINOX chemotherapy response in pancreatic cancer

Kendelle Joan Murphy, Cecilia R. Chambers, Daniel A. Reed…·Paul Timpson

This paper shows that pulsed narmafotinib priming improves chemotherapy response in pancreatic cancer by reducing fibrosis and enhancing treatment efficacy.

DOI 10.64898/2026.07.23.740234

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyCancer DiscoveryPeer-reviewedJun 9, 2025

Federated deep learning enables cancer subtyping by proteomics

Zhaoxiang Cai, Emma L. Boys, Zainab Noor…·Roger R. Reddel

ProCanFDL uses federated deep learning to subtype cancers using proteomic data while preserving privacy, achieving performance gains over local models.

18 citationstop 3%

humanproteomics

𝕏 PostBluesky